Choroidal atrophy in a patient with paraneoplastic retinopathy and anti-TRPM1 antibody

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 369-373

  Ueno, Shinji ^a   Ito, Yasuki ^a   Maruko, Ruka ^a   Kondo, Mineo ^b   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cancer associated retinopathy; Choroidal thickness; Melanocyte; Paraneoplastic retinopathy; TRPM1

Indexed keywords

EID: 84893627973     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S55124     Document Type: Article

References (28)

1. Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol. 1988;106(3):307-311.
2. Alexander KR, Fishman GA, Peachey NS, Marchese AL, Tso MOM. ON response defect in paraneoplastic night blindness with cutaneous malignant-melanoma. Invest Ophthalmol Vis Sci. 1992;33(3):477-483.
3. Milam AH, Saari JC, Jacobson SG, Lubinski WP, Feun LG, Alexander KR. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34(1):91-100.
4. Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol. 2001;21(3):173-187.
5. Miyake Y, Yagasaki K, Horiguchi M, Kawase Y, Kanda T. Congenital stationary night blindness with negative electroretinogram-a new classification. Arch Ophthalmol. 1986;104(7):1013-1020.
6. Sieving PA, Murayama K, Naarendorp F. Push-pull model of the primate photopic electroretinogram-a role for hyperpolarizing neurons in shaping the b-wave. Vis Neurosci. 1994;11(3):519-532.
7. Dhingra A, Fina ME, Neinstein A, etal. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci. 2011;31(11):3962-3967.
8. Kondo M, Sanuki R, Ueno S, etal. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One. 2011;6(5):e19911.
9. Duncan LM, Deeds J, Hunter J, etal. Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. Cancer Res. 1998;58(7):1515-1520.
10. Morgans CW, Zhang J, Jeffrey BG, etal. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci U S A. 2009;106(45):19174-19178.
11. Koike C, Obara T, Uriu Y, etal. TRPM1 is a component of the retinal ON bipolar cell transduction channel in the mGluR6 cascade. Proc Natl Acad Sci U S A. 2010;107(1):332-337.
12. Koike C, Numata T, Ueda H, Mori Y, Furukawa T. TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. Cell Calcium. 2010;48(2-3):95-101.
13. Anastasakis A, Dick AD, Damato EM, Spry PG, Majid MA. Cancer-associated retinopathy presenting as retinal vasculitis with a negative ERG suggestive of on-bipolar cell pathway dysfunction. Doc Ophthalmol. 2011;123(1):59-63.
14. Kim LS, Alexander KR, Fishman GA. Spontaneous improvement of rod system function in a patient with melanoma-associated retinopathy. Retin Cases Brief Rep. 2008;2(2):166-171.
15. Stead RE, Fox MA, Staples E, Lim CS. Delayed presentation of melanoma-associated retinopathy and subsequent resolution with cytoreduction surgery. Doc Ophthalmol. 2013;127(2):165-171.
16. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009;147(5):811-815.
17. Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103-126.
18. Maruko I, Iida T, Sugano Y, etal. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011;31(3): 510-517.
19. Nakai K, Gomi F, Ikuno Y, etal. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250(7): 1089-1095.
20. Nakayama M, Keino H, Okada AA, etal. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Retina. 2012;32(10):2061-2069.
21. Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol. 2011;152(4): 663-668.
22. Zhang X, Zuo C, Li M, Chen H, Huang S, Wen F. Spectral-domain optical coherence tomographic findings at each stage of punctate inner choroidopathy. Ophthalmology. 2013;120(12):2678-2683.
23. Regatieri CV, Branchini L, Fujimoto JG, Duker JS. Choroidal imaging using spectral-domain optical coherence tomography. Retina. 2012;32(5):865-876.
24. Li Z, Sergouniotis PI, Michaelides M, etal. Recessive mutations of the gene TRPM1 abrogate ON bipolar cell function and cause complete congenital stationary night blindness in humans. Am J Hum Genet. 2009;85(5):711-719.
25. Bellone RR, Brooks SA, Sandmeyer L, etal. Differential gene expression of TPLPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the appaloosa horse (Equus caballus). Genetics. 2008;179(4):1861-1870.
26. Devi S, Kedlaya R, Maddodi N, etal. Calcium homeostasis in human melanocytes: role of transient receptor potential melastatin 1 (TRPM1) and its regulation by ultraviolet light. Am J Physiol Cell Physiol. 2009;297(3):C679-C687.
27. Oancea E, Vriens J, Brauchi S, Jun J, Splawski I, Clapham DE. TRPM1 forms ion channels associated with melanin content in melanocytes. Sci Signal. 2009;2(70):ra21.
28. Devi S, Markandeya Y, Maddodi N, etal. Metabotropic glutamate receptor 6 signaling enhances TRPM1 calcium channel function and increases melanin content in human melanocytes. Pigment Cell Melanoma Res. 2013;26(3):348-356.